{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T02:49:38Z","timestamp":1772160578645,"version":"3.50.1"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,11,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Sildenafil treatment has not been evaluated in a double-blind, placebo-controlled (DBPC) trial specific to men with mild erectile dysfunction (ED), defined by a 22\u201325 score on the International Index of Erectile Function-erectile function domain (IIEF-EF).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>To assess sildenafil efficacy in sexually dissatisfied men with mild ED.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcome Measures<\/jats:title>\n                    <jats:p>Erectile Dysfunction Inventory of Treatment Satisfaction (EDITS), IIEF, Quality of Erection Questionnaire (QEQ), Erection Hardness Score (EHS 4 = completely hard\/fully rigid), general efficacy questions (GEQs), event log questions (hardness sufficient for penetration, duration sufficient for successful intercourse, ejaculation\/orgasm, and second erection within 24 hours), and analog scales (erection firmness, reliability, and maintenance, and general sexual performance).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Eight-week DBPC flexible-dose (25, 50, or 100 mg) trial with 6-week, open-label (OL) extension.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>One hundred and seventy-six men were randomized (mean \u00b1 standard deviation: age, 50 \u00b1 12 year; ED duration, 3.5 \u00b1 3.2 year). Most had organic or mixed ED. For sildenafil vs. placebo, 66% vs. 89% titrated to 100 mg and efficacy at DBPC end was better, including the EDITS Index score (least squares mean [standard error], 80.3 [2.3] vs. 62.1 [2.5]; P &amp;lt; 0.0001); treatment satisfaction (EDITS Index score &amp;gt;50 in 89% vs. 63%; P = 0.0001); no ED (IIEF-EF \u226526 in 58% vs. 39%; P &amp;lt; 0.05); GEQs (\u22654.9-fold greater odds of improved erections and ability to have sexual intercourse); and EHS 4 (47.2% vs. 25.2% of occasions; P &amp;lt; 0.0001). At OL end, 93% of men were satisfied (EDITS Index score &amp;gt; 50), 77% had no ED, and \u226589% were GEQ responders; mean scores on IIEF domains, the QEQ, and analog scales were &amp;gt;80% of the maximum; 60% of occasions had EHS 4; and event log responses were positive on &amp;gt;80% of occasions, except for second erections (41.9%). Headache, nasal congestion, and flushing, mostly mild to moderate, were the most common adverse events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Men with mild ED derive substantial benefit from sildenafil treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/j.1743-6109.2010.02015.x","type":"journal-article","created":{"date-parts":[[2010,10,4]],"date-time":"2010-10-04T17:05:10Z","timestamp":1286211910000},"page":"3725-3735","source":"Crossref","is-referenced-by-count":16,"title":["Men with Mild Erectile Dysfunction Benefit from Sildenafil Treatment"],"prefix":"10.1093","volume":"7","author":[{"given":"Francois","family":"B\u00e9nard","sequence":"first","affiliation":[{"name":"CHUM-St-Luc Hospital , Montreal, QC , Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serge","family":"Carrier","sequence":"additional","affiliation":[{"name":"Jewish General Hospital, McGill University , Montreal, QC , Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay C.","family":"Lee","sequence":"additional","affiliation":[{"name":"Rockyview Hospital , Calgary, AB , Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Varun","family":"Talwar","sequence":"additional","affiliation":[{"name":"Sciformix Technologies Pvt. Ltd , Mumbai , India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Defoy","sequence":"additional","affiliation":[{"name":"Pfizer Canada Inc. , Kirkland, QC , Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2010,11,1]]},"reference":[{"key":"2024032522110372300_bb0010","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0022-5347(17)34871-1","article-title":"Impotence and its medical and psychosocial correlates: Results of the Massachusetts Male Aging Study","volume":"151","author":"Feldman","year":"1994","journal-title":"J Urol"},{"key":"2024032522110372300_bb0015","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0022-5347(05)67362-4","article-title":"Effect of erectile dysfunction on frequency of intercourse: A population based prevalence study in Finland","volume":"164","author":"Koskimaki","year":"2000","journal-title":"J Urol"},{"key":"2024032522110372300_bb0020","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1001\/archinte.166.2.213","article-title":"The prevalence of erectile dysfunction in the primay care setting; Importance of risk factors for diabetes and vascular disease","volume":"166","author":"Grover","year":"2006","journal-title":"Arch Intern Med"},{"key":"2024032522110372300_bb0025","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0090-4295(99)00099-0","article-title":"Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function","volume":"54","author":"Cappelleri","year":"1999","journal-title":"Urology"},{"key":"2024032522110372300_bb0030","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S0090-4295(97)00238-0","article-title":"The International Index of Erectile Function (IIEF): A multidimensional scale for assessment of erectile dysfunction","volume":"49","author":"Rosen","year":"1997","journal-title":"Urology"},{"key":"2024032522110372300_bb0035","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1743-6109.2004.04023.x","article-title":"The multinational Men\u2019s Attitudes to Life Events and Sexuality (MALES) Study Phase II: Understanding PDE5 inhibitor treatment seeking patterns, among men with erectile dysfunction","volume":"1","author":"Fisher","year":"2004","journal-title":"J Sex Med"},{"key":"2024032522110372300_bb0040","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1023\/B:QURE.0000018482.71580.f2","article-title":"Development and initial validation of a new preference-based disease-specific health-related quality of life instrument for erectile function","volume":"13","author":"Torrance","year":"2004","journal-title":"Qual Life Res"},{"key":"2024032522110372300_bb0045","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1743-6109.2004.04027.x","article-title":"Vardenafil improves patient satisfaction with erection hardness, orgasmic function, and overall sexual experience, while improving quality of life in men with erectile dysfunction","volume":"1","author":"Donatucci","year":"2004","journal-title":"J Sex Med"},{"key":"2024032522110372300_bb0050","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1743-6109.2005.00119.x","article-title":"Improving the sexual quality of life of couples affected by erectile dysfunction: A double-blind, randomized, placebo-controlled trial of vardenafil","volume":"2","author":"Fisher","year":"2005","journal-title":"J Sex Med"},{"key":"2024032522110372300_bb0055","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1023\/A:1012270220064","article-title":"Efficacy results and quality-of-life measures in men receiving sildenafil citrate for the treatment of erectile dysfunction","volume":"10","author":"Giuliano","year":"2001","journal-title":"Qual Life Res"},{"key":"2024032522110372300_bb0060","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1743-6109.2008.01026.x","article-title":"Self-esteem, confidence, and relationships in Brazilian men with erectile dysfunction receiving sildenafil citrate: A randomized, parallel-group, double-blind, placebo-controlled study in Brazil","volume":"6","author":"Glina","year":"2009","journal-title":"J Sex Med"},{"key":"2024032522110372300_bb0065","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1111\/j.1743-6109.2008.00879.x","article-title":"Effect of sildenafil citrate on the male sexual experience assessed with the Sexual Experience Questionnaire; a multicenter, double-blind, placebo-controlled trial with open-label extension","volume":"5","author":"Jones","year":"2008","journal-title":"J Sex Med"},{"key":"2024032522110372300_bb0070","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/j.1743-6109.2007.00701.x","article-title":"Quality of erections in men treated with flexible-dose sildenafil for erectile dysfunction: Multicenter trial with a double-blind, randomized, placebo-controlled phase and an open-label phase","volume":"5","author":"Kadioglu","year":"2008","journal-title":"J Sex Med"},{"key":"2024032522110372300_bb0075","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/j.1743-6109.2008.01156.x","article-title":"In men with erectile dysfunction, satisfaction with quality of erections correlates with erection hardness, treatment satisfaction, and emotional well-being","volume":"6","author":"Kaminetsky","year":"2009","journal-title":"J Sex Med"},{"key":"2024032522110372300_bb0080","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1111\/j.1743-6109.2009.01428.x","article-title":"Sildenafil citrate 100 mg starting dose in men with erectile dysfunction in an international, double-blind, placebo-controlled study: Effect on the sexual experience and reducing feelings of anxiety about the next intercourse attempt","volume":"6","author":"Loran","year":"2009","journal-title":"J Sex Med"},{"key":"2024032522110372300_bb0085","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1743-6109.2006.00426.x","article-title":"Efficacy of vardenafil and influence on self-esteem and self-confidence in patients with severe erectile dysfunction","volume":"4","author":"Martin-Morales","year":"2007","journal-title":"J Sex Med"},{"key":"2024032522110372300_bb0090","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1111\/j.1743-6109.2009.01514.x","article-title":"Emotional changes in men treated with sildenafil citrate for erectile dysfunction: A double-blind, placebo-controlled clinical trial","volume":"6","author":"Moncada","year":"2009","journal-title":"J Sex Med"},{"key":"2024032522110372300_bb0095","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/j.1743-6109.2007.00527.x","article-title":"The Treatment Satisfaction Scale (TSS) is a sensitive measure of treatment effectiveness for both patients and partners: Results of a randomized controlled trial with vardenafil","volume":"4","author":"Rosen","year":"2007","journal-title":"J Sex Med"},{"key":"2024032522110372300_bb0100","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1111\/j.1743-6109.2009.01222.x","article-title":"Impact on erectile function and sexual quality of life of couples: A double-blind, randomized, placebo-controlled trial of tadalafil taken once daily","volume":"6","author":"Rubio-Aurioles","year":"2009","journal-title":"J Sex Med"},{"key":"2024032522110372300_bb0105","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/ijir.2009.22","article-title":"Improvements in confidence, sexual relationship and satisfaction measures: Results of a randomized trial of tadalafil 5 mg taken once daily","volume":"21","author":"Seftel","year":"2009","journal-title":"Int J Impot Res"},{"key":"2024032522110372300_bb0110","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/ijir.2008.21","article-title":"Sildenafil citrate efficacy 8 hours postdose in men with mild to moderate erectile dysfunction","volume":"20","author":"McCullough","year":"2008","journal-title":"Int J Impot Res"},{"key":"2024032522110372300_bb0115","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.urology.2007.12.025","article-title":"Randomized, double-blind, crossover trial of sildenafil in men with mild to moderate erectile dysfunction: Efficacy at 8 and 12 hours postdose","volume":"71","author":"McCullough","year":"2008","journal-title":"Urology"},{"key":"2024032522110372300_bb0120","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/j.1743-6109.2006.00297.x","article-title":"Prospective, randomized, open-label, fixed-dose, crossover study to establish preference of patients with erectile dysfunction after taking the three PDE-5 inhibitors","volume":"3","author":"Tolra","year":"2006","journal-title":"J Sex Med"},{"key":"2024032522110372300_bb0125","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1745-7262.2007.00233.x","article-title":"Improved spontaneous erectile function in men with mild-to-moderate arteriogenic erectile dysfunction treated with a nightly dose of sildenafil for one year: A randomized trial","volume":"9","author":"Sommer","year":"2007","journal-title":"Asian J Androl"},{"key":"2024032522110372300_bb0130","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.urology.2006.05.001","article-title":"Efficacy and safety of tadalafil 5, 10, and 20 mg in Japanese men with erectile dysfunction: Results of a multicenter, randomized, double-blind, placebo-controlled study","volume":"68","author":"Nagao","year":"2006","journal-title":"Urology"},{"key":"2024032522110372300_bb0135","doi-asserted-by":"crossref","first-page":"310","DOI":"10.2164\/jandrol.04126","article-title":"Tadalafil improved erectile function at twenty-four and thirty-six hours after dosing in men with erectile dysfunction: US trial","volume":"26","author":"Young","year":"2005","journal-title":"J Androl"},{"key":"2024032522110372300_bb0140","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0090-4295(98)00582-2","article-title":"EDITS: Development of questionnaires for evaluating satisfaction with treatments for erectile dysfunction","volume":"53","author":"Althof","year":"1999","journal-title":"Urology"},{"key":"2024032522110372300_bb0145","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1743-6109.2006.00422.x","article-title":"Development and validation of the quality of erection questionnaire","volume":"4","author":"Porst","year":"2007","journal-title":"J Sex Med"},{"key":"2024032522110372300_bb0150","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1111\/j.1743-6109.2007.00600.x","article-title":"Validation of the Erection Hardness Score (EHS)","volume":"4","author":"Mulhall","year":"2007","journal-title":"J Sex Med"},{"key":"2024032522110372300_bb0155","first-page":"975","article-title":"Long-term safety and effectiveness of sildenafil citrate in men with erectile dysfunction","volume":"3","author":"McMurray","year":"2007","journal-title":"Ther Clin Risk Manag"},{"key":"2024032522110372300_bb0160","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.urology.2006.05.041","article-title":"Erection hardness, a unifying factor for defining response in the treatment of erectile dysfunction","volume":"68","author":"Mulhall","year":"2006","journal-title":"Urology"},{"key":"2024032522110372300_bb0165","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1111\/j.1743-6109.2010.01791.x","article-title":"Understanding the effects of sildenafil treatment on erection maintenance and erection hardness","volume":"7","author":"Claes","year":"2010","journal-title":"J Sex Med"},{"key":"2024032522110372300_bb0170","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1111\/j.1743-6109.2010.01882.x","article-title":"Interrelationships of sildenafil treatment effects on the physiological and psychosocial aspects of erectile dysfunction of mixed or organic etiology","volume":"7","author":"Althof","year":"2010","journal-title":"J Sex Med"},{"key":"2024032522110372300_bb0175","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S0090-4295(01)00945-1","article-title":"Patient and partner satisfaction with Viagra (sildenafil citrate) treatment as determined by the erectile dysfunction inventory of treatment satisfaction questionnaire","volume":"57","author":"Lewis","year":"2001","journal-title":"Urology"},{"key":"2024032522110372300_bb0180","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/sj.ijir.3901095","article-title":"Development and validation of the Self-Esteem And Relationship (SEAR) questionnaire in erectile dysfunction","volume":"16","author":"Cappelleri","year":"2004","journal-title":"Int J Impot Res"},{"key":"2024032522110372300_bb0185","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1743-6109.04043.x","article-title":"Vardenafil improves erectile function in men with erectile dysfunction irrespective of disease severity and disease classification","volume":"1","author":"Donatucci","year":"2004","journal-title":"J Sex Med"},{"key":"2024032522110372300_bb0190","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/sj.ijir.3900816","article-title":"Combination therapy for erectile dysfunction: A randomized, double blind, unblinded active-controlled, cross-over study of the pharmacodynamics and safety of combined oral formulations of apomorphine hydrochloride, phentolamine mesylate and papaverine hydrochloride in men with moderate to severe erectile dysfunction","volume":"14","author":"Lammers","year":"2002","journal-title":"Int J Impot Res"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515327466?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515327466?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/7\/11\/3725\/47358714\/jsm_7_11_3725.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/7\/11\/3725\/47358714\/jsm_7_11_3725.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T18:26:34Z","timestamp":1711391194000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/7\/11\/3725\/6848136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,1]]},"references-count":37,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2010,11,1]]},"published-print":{"date-parts":[[2010,11,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1743-6109.2010.02015.x","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.5880959.5869057","asserted-by":"object"}]},"ISSN":["1743-6109","1743-6095"],"issn-type":[{"value":"1743-6109","type":"electronic"},{"value":"1743-6095","type":"print"}],"subject":[],"published-other":{"date-parts":[[2010,11]]},"published":{"date-parts":[[2010,11,1]]}}}